# Axel Dignaß

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/axel-digna/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,727 |
| Field | Inflammatory Bowel Disease |
| h-index | 75 |
| i10-index | 191 |
| Last Known Institution | Goethe University Frankfurt |
| OpenAlex ID | https://openalex.org/A5041223408 |
| ORCID iD | https://orcid.org/0000-0002-9724-054X |
| Works | 544 |

## Researcher papers

- [STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD](https://scholariq.org/papers/stride-ii-an-update-on-the-selecting-therapeutic-targets-in-inflammatory-bowel/)
- [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management](https://scholariq.org/papers/second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of-2/)
- [Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial](https://scholariq.org/papers/expanded-allogeneic-adipose-derived-mesenchymal-stem-cells-cx601-for-complex/)
- [Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease](https://scholariq.org/papers/consensus-guidelines-of-ecco-espghan-on-the-medical-management-of-pediatric/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease](https://scholariq.org/papers/long-term-efficacy-and-safety-of-stem-cell-therapy-cx601-for-complex-perianal/)
- [Management of Pediatric Ulcerative Colitis](https://scholariq.org/papers/management-of-pediatric-ulcerative-colitis/)
- [European evidence based consensus on surgery for ulcerative colitis](https://scholariq.org/papers/european-evidence-based-consensus-on-surgery-for-ulcerative-colitis/)
- [Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting](https://scholariq.org/papers/management-of-patients-with-crohn-s-disease-and-ulcerative-colitis-during-the/)
- [Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study](https://scholariq.org/papers/vedolizumab-provides-clinical-benefit-over-1-year-in-patients-with-active/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Researcher university

- [Goethe University Frankfurt](https://scholariq.org/institutions/goethe-university-frankfurt/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.